Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?

Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?

Source: 
Motley Fool
snippet: 
  • The FDA could soon make a decision on Biogen's Alzheimer's drug, Leqembi.
  • An advisory committee confirmed its clinical benefits, suggesting an approval could be ahead.
  • The market, however, may already be pricing that prospect into Biogen's richly valued shares.